Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
28 Sep 2015 ESMO @ ECC 2015: Comprehensive Genomic Profiling of BRAF in a Large Series of Lung Cancer Samples Translational research - Lung and other thoracic tumours
28 Sep 2015 ESMO @ ECC 2015: Response to EGFR Agents in Combination With Chemotherapy Demonstrated in Patients with Metastatic Colorectal Cancer of Rare KRAS Molecular Subtype Gastrointestinal cancers - Anticancer agents & Biologic therapy
27 Sep 2015 ESMO @ ECC 2015: Progression-Free Survival Prolonged with Everolimus in Patients with Advanced Lung/Gastrointestinal Neuroendocrine Tumours Endocrine cancers - Anticancer agents & Biologic therapy
27 Sep 2015 ESMO @ ECC2015: Greater Clinical Benefit Obtained in Advanced BRAFV600-mutated Melanoma with Cobimetinib/Vemurafenib Over Vemurafenib Is Consistent Across Mutation Subtypes Melanoma - Anticancer agents & Biologic therapy
27 Sep 2015 ESMO @ ECC 2015: Induction with Nivolumab Followed by Ipilimumab Most Effective Temporal Approach in Non-Resectable Melanoma Melanoma - Cancer Immunology and Immunotherapy
27 Sep 2015 ESMO @ ECC 2015: Blocking PD1 Shows Promise in Merkel Cell Carcinoma Melanoma - Cancer Immunology and Immunotherapy
27 Sep 2015 ESMO @ ECC 2015: Novel Atezolizumab Shows Promise in Metastatic Urothelial Carcinoma Genitourinary cancers - Cancer Immunology and Immunotherapy
27 Sep 2015 ESMO @ ECC 2015: Novel Assay Developed to Determine PD-L2 Expression in Tumour Samples Pathology/Molecular biology - Cancer Immunology and Immunotherapy
27 Sep 2015 ESMO Commentary: Atezolizumab Set to Change Refractory Lung Cancer Treatment Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
26 Sep 2015 ESMO @ ECC 2015: Cabozantinib Out-Performs Everolimus in Advanced Renal Cell Carcinoma Genitourinary cancers - Anticancer agents & Biologic therapy
26 Sep 2015 ESMO @ ECC 2015: Regional Hyperthermia Added to Neoadjuvant Chemotherapy Doubles Length of Overall Survival in Patients With Localised High-Risk Soft Tissue Sarcoma Sarcomas - Anticancer agents & Biologic therapy
26 Sep 2015 ESMO @ ECC 2015: TURANDOT: First-Line Bevacizumab Plus Capecitabine Shows Non-Inferior Overall Survival versus Bevacizumab plus Paclitaxel for Metastatic Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
26 Sep 2015 ESMO @ ECC 2015: Anti-tumour Activity Demonstrated with Orteronel in Metastatic Castration Resistant Prostate Cancer Genitourinary cancers - Anticancer agents & Biologic therapy
16 Sep 2015 Advanced Treatment and Prognosis Data Available for TNM Classification of Lung Cancer Lung and other thoracic tumours
15 Sep 2015 First Regulatory Approval of Cobimetinib in Switzerland Melanoma - Anticancer agents & Biologic therapy